OD48 Improving Public Understanding Of Health Technology Assessment Decisions

Introduction Since 2018, the Scottish Medicines Consortium (SMC) has published a plain English summary for each health technology assessment (HTA) decision called Decision Explained (DE). This provides clear information to patients, Patient Group Partners (PGPs), and the public about what SMC’s decisions mean for them. The DE document was evaluated and updated in 2023 to ensure it continues to meet this purpose. Methods The evaluation consisted of two components. All (186) registered PGPs were invited to complete an online five-question survey focusing on the use of the DE document. This included readership, language, and SMC decision-making transparency. A separate focus group for public representatives took place, discussing design, accessibility, and content. Identical sample DE documents were used for both groups for consistency. Survey responses were collated and analyzed. Focus group responses were analyzed using thematic analysis. The DE document was revised, and the new version was considered for implementation by SMC’s Public Involvement Network Advisory Group. Results Survey respondents (n=20) found the DE document helpful or very helpful in improving understanding of SMC advice. Some commented on complex language and information about how the medicine works being irrelevant. The focus group commented on excess information and favored simplified content and structure. Analysis of both sets of research data resulted in several recommended changes. These included the decision statement being moved to the start of the document, the language being simplified, and the section on how a medicine works being removed. Revised documents including these changes were prepared and were reviewed and approved by the SMC’s Public Involvement Network Advisory Group. Conclusions Published plain English explanations are helpful for improving patient and public understanding of HTA decisions for new medicines. It is important this information is concise, relevant, and aligned to accessibility good practice. The recent review of the SMC DE documents led to changes that help to ensure they meet the needs of stakeholders.

Authors

Publication Details

Journal
International Journal of Technology Assessment in Health Care
Published
2024-12-01
DOI
https://doi.org/10.1017/s0266462324001740
Primary Topic
Biotechnology and Related Fields
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

OD48 Improving Public Understanding Of Health Technology Assessment Decisions

Jackie McCormack, Jennifer Dickson, Kate Russell, Daniel Cairns
International Journal of Technology Assessment in Health Care
Biotechnology and Related Fields
article

OD48 Improving Public Understanding Of Health Technology Assessment Decisions

Jackie McCormack, Jennifer Dickson, Kate Russell, Daniel Cairns
article en

Abstract

Introduction Since 2018, the Scottish Medicines Consortium (SMC) has published a plain English summary for each health technology assessment (HTA) decision called Decision Explained (DE). This provides clear information to patients, Patient Group Partners (PGPs), and the public about what SMC’s decisions mean for them. The DE document was evaluated and updated in 2023 to ensure it continues to meet this purpose. Methods The evaluation consisted of two components. All (186) registered PGPs were invited to complete an online five-question survey focusing on the use of the DE document. This included readership, language, and SMC decision-making transparency. A separate focus group for public representatives took place, discussing design, accessibility, and content. Identical sample DE documents were used for both groups for consistency. Survey responses were collated and analyzed. Focus group responses were analyzed using thematic analysis. The DE document was revised, and the new version was considered for implementation by SMC’s Public Involvement Network Advisory Group. Results Survey respondents (n=20) found the DE document helpful or very helpful in improving understanding of SMC advice. Some commented on complex language and information about how the medicine works being irrelevant. The focus group commented on excess information and favored simplified content and structure. Analysis of both sets of research data resulted in several recommended changes. These included the decision statement being moved to the start of the document, the language being simplified, and the section on how a medicine works being removed. Revised documents including these changes were prepared and were reviewed and approved by the SMC’s Public Involvement Network Advisory Group. Conclusions Published plain English explanations are helpful for improving patient and public understanding of HTA decisions for new medicines. It is important this information is concise, relevant, and aligned to accessibility good practice. The recent review of the SMC DE documents led to changes that help to ensure they meet the needs of stakeholders.

International Journal of Technology Assessment in Health CareVol. 40(S1)
Openalex Percentile: Top 62%
Biotechnology and Related Fields
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

OD48 Improving Public Understanding Of Health Technology Assessment Decisions — Jackie McCormack, Jennifer Dickson, et al. · International Journal of Technology Assessment in Health Care (2024) | TGRS Research Map | TGRS